SpyGlass Pharma, Inc. Common Stock Stock Analysis & AI Score
SpyGlass Pharma, Inc. Common Stock (SGP) has an ST Score of 61.2 (B), driven by its Financial Strength (A+) and held back by its Growth (F). SGP last traded at $27.65.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
SpyGlass Pharma, Inc. Common Stock (SGP) has an ST Score of 61.2 (B), driven by its Financial Strength (A+) and held back by its Growth (F). SGP last traded at $27.65.
- Strongest
- Financial StrengthA+
- Weakest
- GrowthF
All factor grades
- Financial StrengthA+
- MomentumA+
- ForecastB
- ValuationB-
- ProfitabilityB-
- GrowthF
Contact
SGP stock: frequently asked questions
What is SGP's ST Score?
SpyGlass Pharma, Inc. Common Stock (SGP) has an ST Score of 61.2 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SGP a buy, hold, or sell?
Our ST Score grades it B (61.2/100). The ST Score is a data-driven signal, not a recommendation.
What are SGP's factor grades?
Valuation B-, Profitability B-, Financial Strength A+, Momentum A+, Growth F, Forecast B.
What is SGP's valuation grade?
SpyGlass Pharma, Inc. Common Stock (SGP) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SGP's growth grade?
SpyGlass Pharma, Inc. Common Stock (SGP) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SGP's profitability grade?
SpyGlass Pharma, Inc. Common Stock (SGP) earns a profitability grade of B-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SGP's financial strength grade?
SpyGlass Pharma, Inc. Common Stock (SGP) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SGP?
The average analyst price target for SpyGlass Pharma, Inc. Common Stock (SGP) is $39.00, which is +41.0% versus the recent price of $27.65.